back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2020-12-23 08:51 Tx date 2020-12-22 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,550
+9,500 vol $0.90 each |
45,000 | |
| Filed 2020-12-23 08:50 Tx date 2020-12-22 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,355
+16,500 vol $0.87 each |
35,500 | |
| Filed 2020-12-23 08:45 Tx date 2020-12-22 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,740
+9,000 vol $0.86 each |
19,000 | |
| Filed 2020-11-20 15:28 Tx date 2020-11-20 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,626.61
-8,181 vol $0.81 each |
10,000 | |
| Filed 2020-11-20 15:26 Tx date 2020-11-18 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-19,920
-24,000 vol $0.83 each |
18,181 | |
| Filed 2020-09-16 13:07 Tx date 2020-09-14 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chiasson, Bernard
5 - Senior Officer of Issuer
Holder: BJC Integrated Scientific Management Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,991
+3,835 vol $0.78 each |
9,485 | |
| Filed 2020-07-02 09:51 Tx date 2020-06-30 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,530
+7,000 vol $0.79 each |
75,000 | |
| Filed 2020-06-17 12:47 Tx date 2020-06-16 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,200
+1,500 vol $0.80 each |
98,886 | |
| Filed 2020-06-17 12:46 Tx date 2020-06-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
97,386 | |
| Filed 2020-06-16 16:11 Tx date 2020-06-16 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-3,288 vol |
183,850 | |
| Filed 2020-06-16 16:09 Tx date 2020-06-16 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-16,608 vol |
139,025 | |
| Filed 2020-06-16 16:06 Tx date 2020-06-16 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-16,608 vol |
328,283 | |
| Filed 2020-06-15 16:54 Tx date 2020-06-12 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,975
+2,500 vol $0.79 each |
94,886 | |
| Filed 2020-06-12 13:23 Tx date 2020-06-11 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
92,386 | |
| Filed 2020-06-11 13:58 Tx date 2020-06-10 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,340
+3,000 vol $0.78 each |
68,000 | |
| Filed 2020-06-11 13:56 Tx date 2020-06-10 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
89,886 | |
| Filed 2020-06-10 14:07 Tx date 2020-03-13 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,120
+2,000 vol $0.56 each |
36,000 | |
| Filed 2020-06-10 13:25 Tx date 2020-06-09 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
87,386 | |
| Filed 2020-06-10 10:34 Tx date 2020-06-05 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,304
+8,000 vol $0.79 each |
63,000 | |
| Filed 2020-06-09 13:40 Tx date 2020-06-08 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
84,886 | |
| Filed 2020-06-08 16:05 Tx date 2020-06-05 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,955
+2,500 vol $0.78 each |
82,386 | |
| Filed 2020-06-05 12:21 Tx date 2020-06-04 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
79,886 | |
| Filed 2020-06-04 12:09 Tx date 2020-06-03 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,870
+2,500 vol $0.75 each |
77,386 | |
| Filed 2020-06-03 17:42 Tx date 2020-06-02 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
74,886 | |
| Filed 2020-06-02 17:27 Tx date 2020-06-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,955
+2,500 vol $0.78 each |
72,386 | |
| Filed 2020-06-01 16:17 Tx date 2020-05-29 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
69,886 | |
| Filed 2020-05-29 15:38 Tx date 2020-05-28 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,060
+2,500 vol $0.82 each |
67,386 | |
| Filed 2020-05-28 15:49 Tx date 2020-05-27 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
64,886 | |
| Filed 2020-05-28 15:46 Tx date 2020-05-26 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
62,386 | |
| Filed 2020-05-26 17:20 Tx date 2020-05-25 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,975
+2,500 vol $0.79 each |
59,886 | |
| Filed 2020-05-25 14:53 Tx date 2020-05-22 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
57,386 | |
| Filed 2020-05-22 12:54 Tx date 2020-05-21 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
54,886 | |
| Filed 2020-05-21 15:01 Tx date 2020-05-20 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
52,386 | |
| Filed 2020-05-20 16:46 Tx date 2020-05-19 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,750
+2,500 vol $0.70 each |
49,886 | |
| Filed 2020-05-19 15:14 Tx date 2020-05-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,675
+2,500 vol $0.67 each |
47,386 | |
| Filed 2020-05-19 15:04 Tx date 2020-05-14 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,650
+5,000 vol $0.73 each |
55,000 | |
| Filed 2020-05-19 15:02 Tx date 2020-05-14 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,000
+10,000 vol $0.70 each |
50,000 | |
| Filed 2020-05-15 12:28 Tx date 2020-05-14 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,825
+2,500 vol $0.73 each |
44,886 | |
| Filed 2020-05-15 12:22 Tx date 2020-05-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Demerino, Kelly
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$268.00
+400 vol $0.67 each |
1,200 | |
| Filed 2020-05-14 14:09 Tx date 2020-05-13 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
32,840 | |
| Filed 2020-05-14 14:07 Tx date 2020-05-13 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
32,840 | |
| Filed 2020-05-14 14:01 Tx date 2020-05-13 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
155,633 | |
| Filed 2020-05-14 13:58 Tx date 2020-05-13 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
344,891 | |
| Filed 2020-05-14 13:54 Tx date 2020-05-13 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
110,655 | |
| Filed 2020-03-27 16:24 Tx date 2020-03-27 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Berardelli, Luigi
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
47,500 | |
| Filed 2020-03-27 16:20 Tx date 2020-03-27 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
187,138 | |
| Filed 2020-03-27 16:17 Tx date 2020-03-27 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chiasson, Bernard
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
94,220 | |
| Filed 2020-03-27 16:13 Tx date 2020-03-27 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Demerino, Kelly
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+18,750 vol |
18,750 | |
| Filed 2020-03-27 16:11 Tx date 2020-03-16 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Demerino, Kelly
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-03-27 16:08 Tx date 2020-03-27 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+6,250 vol |
93,158 | |
| Filed 2020-03-27 16:05 Tx date 2020-03-27 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
299,908 | |
| Filed 2020-03-27 15:58 Tx date 2020-03-27 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,680
+2,500 vol $0.67 each |
42,386 | |
| Filed 2020-03-27 15:58 Tx date 2020-03-25 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,625
+2,500 vol $0.65 each |
39,886 | |
| Filed 2020-03-25 18:15 Tx date 2020-03-24 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,625
+2,500 vol $0.65 each |
37,386 | |
| Filed 2020-03-25 18:12 Tx date 2020-03-25 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,200
+2,000 vol $0.60 each |
40,000 | |
| Filed 2020-03-25 18:12 Tx date 2020-03-25 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,320
+4,000 vol $0.58 each |
38,000 | |
| Filed 2020-03-24 10:31 Tx date 2020-03-23 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,525
+2,500 vol $0.61 each |
34,886 | |
| Filed 2020-03-23 17:11 Tx date 2020-03-19 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chiasson, Bernard
5 - Senior Officer of Issuer
Holder: Spousal RRSP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,360
+3,210 vol $0.74 each |
8,118 | |
| Filed 2020-03-20 12:38 Tx date 2020-03-19 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,830
+2,500 vol $0.73 each |
32,386 | |
| Filed 2020-03-18 17:41 Tx date 2020-03-17 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chiasson, Bernard
5 - Senior Officer of Issuer
Holder: BJC Integrated Scientific Management Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,680
+4,000 vol $0.67 each |
5,650 | |
| Filed 2020-03-18 17:40 Tx date 2020-03-17 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chiasson, Bernard
5 - Senior Officer of Issuer
Holder: BJC Integrated Scientific Management Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$355.00
+500 vol $0.71 each |
1,650 | |
| Filed 2020-03-18 09:25 Tx date 2020-03-16 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Demerino, Kelly
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
800 | ||
| Filed 2020-03-17 15:14 Tx date 2020-03-16 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,875
+2,500 vol $0.75 each |
29,886 | |
| Filed 2020-03-16 17:05 Tx date 2020-03-13 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,795
+2,500 vol $0.72 each |
27,386 | |
| Filed 2020-03-12 16:23 Tx date 2020-03-11 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
24,886 | |
| Filed 2020-03-11 11:02 Tx date 2020-03-10 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,265
+2,500 vol $0.91 each |
22,386 | |
| Filed 2020-03-09 14:56 Tx date 2020-03-06 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,080
+2,500 vol $0.83 each |
19,886 | |
| Filed 2020-03-06 16:19 Tx date 2020-03-05 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$840.00
+1,000 vol $0.84 each |
34,000 | |
| Filed 2020-03-06 16:18 Tx date 2020-03-05 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,075
+2,500 vol $0.83 each |
33,000 | |
| Filed 2020-03-06 16:18 Tx date 2020-03-05 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,645
+4,500 vol $0.81 each |
30,500 | |
| Filed 2020-03-06 16:16 Tx date 2020-03-05 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,600
+2,000 vol $0.80 each |
26,000 | |
| Filed 2020-03-06 16:10 Tx date 2020-03-04 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,880
+4,000 vol $0.97 each |
24,000 | |
| Filed 2020-03-05 15:57 Tx date 2020-03-05 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,448
+2,915 vol $0.84 each |
42,181 | |
| Filed 2020-03-05 11:23 Tx date 2020-03-04 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,415
+2,500 vol $0.97 each |
17,386 | |
| Filed 2020-03-04 16:18 Tx date 2020-03-02 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,200
+8,000 vol $0.90 each |
20,000 | |
| Filed 2020-03-02 13:46 Tx date 2020-02-24 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Berardelli, Luigi
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-03-02 13:43 Tx date 2020-02-28 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,480
+4,000 vol $0.87 each |
12,000 | |
| Filed 2020-03-02 13:42 Tx date 2020-02-28 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,520
+4,000 vol $0.88 each |
8,000 | |
| Filed 2020-03-02 13:42 Tx date 2020-02-28 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,880
+2,000 vol $0.94 each |
4,000 | |
| Filed 2020-03-02 13:41 Tx date 2020-02-27 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,780
+2,000 vol $0.89 each |
2,000 | |
| Filed 2020-03-02 13:40 Tx date 2017-05-11 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-03-02 13:35 Tx date 2020-02-24 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chiasson, Bernard
5 - Senior Officer of Issuer
Holder: BJC Integrated Scientific Management Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,150 | ||
| Filed 2020-02-27 17:09 Tx date 2020-02-24 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chiasson, Bernard
5 - Senior Officer of Issuer
Holder: Spousal RRSP (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
4,908 | ||
| Filed 2020-02-27 17:05 Tx date 2020-02-24 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chiasson, Bernard
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
69,220 | ||
| Filed 2020-02-27 16:49 Tx date 2020-02-24 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Berardelli, Luigi
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
22,500 | ||
| Filed 2019-08-20 09:57 Tx date 2019-08-19 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
148,633 | |
| Filed 2019-08-20 09:47 Tx date 2019-08-19 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
25,840 | |
| Filed 2019-08-19 15:30 Tx date 2019-08-19 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
337,891 | |
| Filed 2019-08-19 15:27 Tx date 2019-08-19 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
25,840 | |
| Filed 2019-04-16 10:14 Tx date 2019-04-05 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+22,500 vol |
162,138 | |
| Filed 2019-04-16 10:10 Tx date 2019-04-05 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+45,000 vol |
199,908 | |
| Filed 2019-04-16 10:01 Tx date 2019-04-05 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+22,500 vol |
86,908 | |
| Filed 2019-01-10 Tx date 2019-01-10 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
103,655 | |
| Filed 2019-01-03 Tx date 2019-01-03 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase
|
-8,406 vol |
0 | |
| Filed 2019-01-03 Tx date 2019-01-03 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase
|
-17,195 vol |
0 | |
| Filed 2019-01-03 Tx date 2019-01-03 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase
|
-17,195 vol |
0 | |
| Filed 2018-10-04 Tx date 2018-10-03 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+8,500 vol |
64,408 | |
| Filed 2018-07-16 Tx date 2018-07-13 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-11,098 vol |
0 | |
| Filed 2018-07-09 Tx date 2018-07-06 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,330
+500 vol $2.66 each |
11,098 | |
| Filed 2018-07-09 Tx date 2018-07-05 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,160
+800 vol $2.70 each |
10,598 | |
| Filed 2018-07-09 Tx date 2018-07-04 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-50,298 vol |
9,798 | |
| Filed 2018-07-07 Tx date 2018-07-03 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,157
+800 vol $2.70 each |
56,047 | |
| Filed 2018-07-07 Tx date 2018-07-04 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$10,729
+4,049 vol $2.65 each |
60,096 | |
| Filed 2018-07-03 Tx date 2018-06-28 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,685
+2,500 vol $2.67 each |
52,798 | |
| Filed 2018-07-03 Tx date 2018-06-29 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,575
+2,449 vol $2.68 each |
55,247 | |
| Filed 2018-06-29 Tx date 2018-06-27 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,700
+1,000 vol $2.70 each |
50,298 | |
| Filed 2018-06-29 Tx date 2018-06-26 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,736
+1,000 vol $2.74 each |
49,298 | |
| Filed 2018-06-26 Tx date 2018-06-22 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$780.00
+300 vol $2.60 each |
47,598 | |
| Filed 2018-06-26 Tx date 2018-06-25 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,900
+700 vol $2.72 each |
48,298 | |
| Filed 2018-06-25 Tx date 2018-06-21 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$10,540
+4,000 vol $2.63 each |
47,298 | |
| Filed 2018-06-25 Tx date 2018-06-20 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,505
+1,700 vol $2.65 each |
43,298 | |
| Filed 2018-06-22 Tx date 2018-06-18 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,200
+2,000 vol $2.60 each |
39,949 | |
| Filed 2018-06-22 Tx date 2018-06-19 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,369
+1,649 vol $2.65 each |
41,598 | |
| Filed 2018-06-18 Tx date 2018-06-14 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,979
+1,500 vol $2.65 each |
33,949 | |
| Filed 2018-06-18 Tx date 2018-06-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$10,710
+4,000 vol $2.68 each |
37,949 | |
| Filed 2018-06-18 Tx date 2018-06-13 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$10,880
+4,049 vol $2.69 each |
32,449 | |
| Filed 2018-06-15 Tx date 2018-06-12 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$270.00
+100 vol $2.70 each |
28,400 | |
| Filed 2018-06-12 Tx date 2018-06-08 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,580
+2,400 vol $2.74 each |
28,300 | |
| Filed 2018-06-12 Tx date 2018-06-07 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,390
+3,100 vol $2.71 each |
25,900 | |
| Filed 2018-06-11 Tx date 2018-06-06 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$10,800
+4,000 vol $2.70 each |
22,800 | |
| Filed 2018-06-06 Tx date 2018-06-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-10,098 vol |
10,800 | |
| Filed 2018-06-06 Tx date 2018-06-05 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,040
+4,000 vol $2.76 each |
18,800 | |
| Filed 2018-06-06 Tx date 2018-06-04 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,040
+4,000 vol $2.76 each |
14,800 | |
| Filed 2018-06-06 Tx date 2018-06-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,520
+4,000 vol $2.88 each |
20,898 | |
| Filed 2018-05-31 Tx date 2018-05-31 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,200
+4,000 vol $2.80 each |
16,898 | |
| Filed 2018-05-30 Tx date 2018-05-30 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,839
+2,800 vol $2.80 each |
12,898 | |
| Filed 2018-05-30 Tx date 2018-05-29 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,018
+1,400 vol $2.87 each |
10,098 | |
| Filed 2018-05-29 Tx date 2018-05-24 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,584
+1,249 vol $2.87 each |
6,298 | |
| Filed 2018-05-29 Tx date 2018-05-28 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,370
+2,200 vol $2.90 each |
8,698 | |
| Filed 2018-05-29 Tx date 2018-05-25 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$574.00
+200 vol $2.87 each |
6,498 | |
| Filed 2018-05-23 Tx date 2018-05-22 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,625
+4,049 vol $2.87 each |
5,049 | |
| Filed 2018-05-23 Tx date 2018-05-18 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,908
+1,000 vol $2.91 each |
1,000 | |
| Filed 2018-05-17 Tx date 2018-05-16 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+5,390 vol |
9,390 | |
| Filed 2018-05-17 Tx date 2018-05-16 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-5,390 vol |
1,000 | |
| Filed 2018-05-16 Tx date 2018-05-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$306.00
+100 vol $3.06 each |
12,486 | |
| Filed 2018-05-16 Tx date 2018-05-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,564
+1,200 vol $2.97 each |
11,286 | |
| Filed 2018-05-16 Tx date 2018-05-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,788
+600 vol $2.98 each |
11,886 | |
| Filed 2018-05-16 Tx date 2018-05-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$301.00
+100 vol $3.01 each |
11,986 | |
| Filed 2018-05-16 Tx date 2018-05-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$302.00
+100 vol $3.02 each |
12,086 | |
| Filed 2018-05-16 Tx date 2018-05-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$303.00
+100 vol $3.03 each |
12,186 | |
| Filed 2018-05-16 Tx date 2018-05-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$304.00
+100 vol $3.04 each |
12,286 | |
| Filed 2018-05-16 Tx date 2018-05-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$305.00
+100 vol $3.05 each |
12,386 | |
| Filed 2018-05-16 Tx date 2018-05-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$307.00
+100 vol $3.07 each |
12,586 | |
| Filed 2018-05-16 Tx date 2018-05-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$308.00
+100 vol $3.08 each |
12,686 | |
| Filed 2018-05-16 Tx date 2018-05-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$309.00
+100 vol $3.09 each |
12,786 | |
| Filed 2018-05-16 Tx date 2018-05-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$310.00
+100 vol $3.10 each |
12,886 | |
| Filed 2018-05-16 Tx date 2018-05-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$311.00
+100 vol $3.11 each |
12,986 | |
| Filed 2018-05-16 Tx date 2018-05-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,652
+1,800 vol $3.14 each |
14,786 | |
| Filed 2018-05-16 Tx date 2018-05-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$318.00
+100 vol $3.18 each |
14,886 | |
| Filed 2018-05-07 Tx date 2018-05-06 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-2,688 vol |
18,840 | |
| Filed 2018-05-07 Tx date 2018-05-06 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-2,688 vol |
18,840 | |
| Filed 2018-05-07 Tx date 2018-05-06 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Messier, Jacques
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-2,688 vol |
18,840 | |
| Filed 2018-04-16 Tx date 2018-04-13 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-164,049 vol |
0 | |
| Filed 2018-04-09 Tx date 2018-04-09 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$495,000
+150,000 vol $3.30 each |
164,049 | |
| Filed 2018-04-04 Tx date 2018-03-28 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$13,151
+3,600 vol $3.65 each |
3,600 | |
| Filed 2018-04-04 Tx date 2018-03-29 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,750
+1,000 vol $3.75 each |
4,600 | |
| Filed 2018-04-04 Tx date 2018-03-28 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-04-04 Tx date 2018-04-04 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,100
+2,500 vol $3.24 each |
14,049 | |
| Filed 2018-04-04 Tx date 2018-04-03 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,716
+2,949 vol $3.29 each |
11,549 | |
| Filed 2018-04-04 Tx date 2018-04-02 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Nuvo Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$13,200
+4,000 vol $3.30 each |
8,600 | |
| Filed 2018-03-29 Tx date 2017-02-13 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Fisher, John
3 - 10% Security Holder of Issuer
Holder: Draper Fisher Jurvetson ePlanet Partnership Fund LLC, Draper Fisher Jurvetson ePlanet Ventures LP, Draper Fisher Jurvets (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
-53,117,243 vol |
0 | |
| Filed 2018-03-29 Tx date 2018-03-28 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$19,996
+5,390 vol $3.71 each |
6,390 | |
| Filed 2018-03-29 Tx date 2017-11-07 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-53,846 vol |
134,633 | |
| Filed 2018-03-29 Tx date 2017-12-06 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-53,846 vol |
||
| Filed 2018-03-29 Tx date 2017-02-13 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Draper, Tim
3 - 10% Security Holder of Issuer
Holder: Draper Fisher Jurvetson ePlanet Partnersh Fund LLC, Draper Fisher Jurvetson ePlanet Ventures LP, Draper Fisher Jurvetson (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
-53,117,243 vol |
0 | |
| Filed 2018-03-29 Tx date 2017-02-13 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Jurvetson, Steve
3 - 10% Security Holder of Issuer
Holder: Draper Fisher Jurvetson ePlanet Partners Fund LLC, Draper Fisher Jurvetson ePlanet Ventures L.P., Draper Fisher Jurvetso (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
-53,117,243 vol |
0 | |
| Filed 2018-03-29 Tx date 2018-03-28 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$29,999
+8,086 vol $3.71 each |
10,086 | |
| Filed 2018-03-29 Tx date 2017-11-07 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-53,846 vol |
323,891 | |
| Filed 2018-03-29 Tx date 2017-12-06 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-53,846 vol |
||
| Filed 2018-03-29 Tx date 2018-03-28 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$19,996
+5,390 vol $3.71 each |
13,855 | |
| Filed 2018-03-28 Tx date 2018-03-28 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Rusaw, Norla Nicole
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$63,900
+18,000 vol $3.55 each |
18,000 | |
| Filed 2018-03-28 Tx date 2018-03-28 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
154,908 | |
| Filed 2018-03-28 Tx date 2018-03-28 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
330,891 | |
| Filed 2018-03-28 Tx date 2018-03-28 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
139,638 | |
| Filed 2018-03-28 Tx date 2018-03-28 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Messier, Jacques
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
21,528 | |
| Filed 2018-03-28 Tx date 2017-08-28 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Rusaw, Norla Nicole
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-28 Tx date 2018-03-28 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
141,633 | |
| Filed 2018-03-28 Tx date 2018-03-28 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
21,528 | |
| Filed 2018-03-28 Tx date 2018-03-28 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
21,528 | |
| Filed 2018-03-28 Tx date 2018-03-28 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
28,655 | |
| Filed 2018-03-13 Tx date 2018-03-13 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-473 vol |
155,313 | |
| Filed 2018-03-13 Tx date 2004-09-21 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-13 Tx date 2018-03-13 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+473 vol |
473 | |
| Filed 2018-02-21 Tx date 2018-02-20 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-7,691 vol |
114,638 | |
| Filed 2018-01-03 Tx date 2018-01-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase
|
-17,193 vol |
39,379 | |
| Filed 2018-01-03 Tx date 2018-01-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
59 - Exercise for cash
|
$-82,080.80
-22,184 vol $3.70 each |
17,195 | |
| Filed 2018-01-03 Tx date 2018-01-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase
|
-17,193 vol |
39,379 | |
| Filed 2018-01-03 Tx date 2018-01-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
59 - Exercise for cash
|
$-82,080.80
-22,184 vol $3.70 each |
17,195 | |
| Filed 2018-01-03 Tx date 2018-01-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase
|
-8,404 vol |
19,250 | |
| Filed 2018-01-03 Tx date 2018-01-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
59 - Exercise for cash
|
$-40,122.80
-10,844 vol $3.70 each |
8,406 | |
| Filed 2017-12-06 Tx date 2017-12-06 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-53,846 vol |
323,891 | |
| Filed 2017-12-06 Tx date 2017-12-06 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-53,846 vol |
134,633 | |
| Filed 2017-05-23 Tx date 2017-05-19 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+5,434 vol |
21,655 | |
| Filed 2017-05-23 Tx date 2017-05-19 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+16,221 vol |
16,221 | |
| Filed 2017-05-23 Tx date 2017-05-11 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-05-05 Tx date 2017-05-05 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-1,050 vol |
14,528 | |
| Filed 2017-05-05 Tx date 2017-05-05 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Messier, Jacques
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-1,050 vol |
14,528 | |
| Filed 2017-05-05 Tx date 2017-05-05 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-1,050 vol |
14,528 | |
| Filed 2017-03-08 Tx date 2017-03-07 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+92,408 vol |
377,737 | |
| Filed 2017-03-08 Tx date 2017-03-07 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Loucaides, Katina
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Options
50 - Grant of options
|
+56,867 vol |
122,329 | |
| Filed 2017-03-08 Tx date 2017-03-07 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Messier, Jacques
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+5,687 vol |
15,578 | |
| Filed 2017-03-08 Tx date 2017-03-07 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+71,083 vol |
104,908 | |
| Filed 2017-03-08 Tx date 2017-03-07 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+5,687 vol |
15,578 | |
| Filed 2017-03-08 Tx date 2017-03-07 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+5,687 vol |
15,578 | |
| Filed 2017-03-08 Tx date 2017-03-07 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+5,687 vol |
188,479 | |
| Filed 2017-03-08 Tx date 2017-03-07 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+49,758 vol |
55,908 | |
| Filed 2017-01-04 Tx date 2017-01-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Loucaides, Katina
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
59 - Exercise for cash
|
$-226,000
-40,000 vol $5.65 each |
27,654 | |
| Filed 2017-01-04 Tx date 2017-01-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
59 - Exercise for cash
|
$-462,328.20
-81,828 vol $5.65 each |
56,572 | |
| Filed 2017-01-04 Tx date 2017-01-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
59 - Exercise for cash
|
$-462,328.20
-81,828 vol $5.65 each |
56,572 | |
| Filed 2016-12-23 Tx date 2016-12-20 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$13,020
+2,000 vol $6.51 each |
2,000 | |
| Filed 2016-12-23 Tx date 2016-04-04 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-09-12 Tx date 2016-09-12 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
6,150 | ||
| Filed 2016-09-12 Tx date 2016-09-12 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
4,000 | ||
| Filed 2016-09-12 Tx date 2016-09-12 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,000 | ||
| Filed 2016-06-27 Tx date 2016-06-27 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Messier, Jacques
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-418 vol |
9,891 | |
| Filed 2016-06-27 Tx date 2016-06-27 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-418 vol |
9,891 | |
| Filed 2016-06-27 Tx date 2016-06-27 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-418 vol |
9,891 | |
| Filed 2016-04-05 Tx date 2016-04-04 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
33,825 | ||
| Filed 2016-03-24 Tx date 2016-03-23 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+9,231 vol |
9,231 | |
| Filed 2016-03-24 Tx date 2015-11-03 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-03-24 Tx date 2016-03-23 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Loucaides, Katina
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Options
50 - Grant of options
|
+15,037 vol |
65,462 | |
| Filed 2016-03-24 Tx date 2016-03-23 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+102,537 vol |
285,329 | |
| Filed 2016-03-24 Tx date 2016-03-23 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Lemieux, Stephen
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Options
50 - Grant of options
|
+28,912 vol |
90,549 | |
| Filed 2016-03-14 Tx date 2013-10-30 |
$NRI
Nuvo Research Inc. (formerly Dimethaid Research Inc.) |
London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+169,807 vol |
169,807 | |
| Filed 2016-03-14 Tx date 2013-10-30 |
$NRI
Nuvo Research Inc. (formerly Dimethaid Research Inc.) |
London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+169,447 vol |
||
| Filed 2016-03-14 Tx date 2013-10-30 |
$NRI
Nuvo Research Inc. (formerly Dimethaid Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+169,807 vol |
169,807 | |
| Filed 2016-03-14 Tx date 2013-10-30 |
$NRI
Nuvo Research Inc. (formerly Dimethaid Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+169,447 vol |
||
| Filed 2016-03-04 Tx date 2016-03-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Lindeiner, Klaus
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+33,662 vol |
35,200 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Stanley, Theodore H.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
38 - Redemption, retraction, cancellation, repurchase
|
-12,183 vol |
0 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Stanley, Theodore H.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
36 - Conversion or exchange
|
-30,154 vol |
12,183 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Stanley, Theodore H.
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$909,263,716
+30,154 vol $30,154 each |
111,127 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
38 - Redemption, retraction, cancellation, repurchase
|
-32 vol |
0 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
36 - Conversion or exchange
|
-3,778 vol |
32 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$14,273,284
+3,778 vol $3,778 each |
13,778 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Messier, Jacques
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
38 - Redemption, retraction, cancellation, repurchase
|
-15,260 vol |
0 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Messier, Jacques
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
36 - Conversion or exchange
|
-34,509 vol |
15,260 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Messier, Jacques
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+34,509 vol |
34,523 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
38 - Redemption, retraction, cancellation, repurchase
|
-43,882 vol |
0 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
36 - Conversion or exchange
|
-57,072 vol |
43,882 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+57,072 vol |
155,786 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Lindeiner, Klaus
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
38 - Redemption, retraction, cancellation, repurchase
|
-14,777 vol |
0 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Lindeiner, Klaus
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
36 - Conversion or exchange
|
-33,662 vol |
14,777 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
38 - Redemption, retraction, cancellation, repurchase
|
-15,449 vol |
0 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
36 - Conversion or exchange
|
-34,666 vol |
15,449 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+34,666 vol |
39,266 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
38 - Redemption, retraction, cancellation, repurchase
|
-17,402 vol |
0 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
36 - Conversion or exchange
|
-37,313 vol |
17,402 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+37,313 vol |
57,692 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
38 - Redemption, retraction, cancellation, repurchase
|
-43,882 vol |
0 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
36 - Conversion or exchange
|
-57,072 vol |
43,882 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+57,072 vol |
223,157 | |
| Filed 2016-02-29 Tx date 2013-10-30 |
$NRI
Nuvo Research Inc. (formerly Dimethaid Research Inc.) |
Lemieux, Stephen
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+90,758 vol |
||
| Filed 2016-02-29 Tx date 2016-02-29 |
$NRI
Nuvo Research Inc. |
Stanley, Theodore H.
4 - Director of Issuer
Direct Ownership
|
Options
97 - Other
|
-2 vol |
9,228 | |
| Filed 2016-02-29 Tx date 2016-02-29 |
$NRI
Nuvo Research Inc. |
Stanley, Theodore H.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
97 - Other
|
+3 vol |
42,337 | |
| Filed 2016-02-29 Tx date 2016-02-29 |
$NRI
Nuvo Research Inc. |
Messier, Jacques
4 - Director of Issuer
Direct Ownership
|
Options
97 - Other
|
-3 vol |
10,309 | |
| Filed 2016-02-29 Tx date 2016-02-29 |
$NRI
Nuvo Research Inc. |
Messier, Jacques
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
97 - Other
|
+6 vol |
49,769 | |
| Filed 2016-02-29 Tx date 2016-02-29 |
$NRI
Nuvo Research Inc. |
Loucaides, Katina
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Options
97 - Other
|
-7 vol |
50,425 | |
| Filed 2016-02-29 Tx date 2013-10-30 |
$NRI
Nuvo Research Inc. (formerly Dimethaid Research Inc.) |
Lemieux, Stephen
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+95,758 vol |
95,758 | |
| Filed 2016-02-29 Tx date 2016-02-29 |
$NRI
Nuvo Research Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Options
97 - Other
|
-7 vol |
182,792 | |
| Filed 2016-02-29 Tx date 2016-02-29 |
$NRI
Nuvo Research Inc. |
Lindeiner, Klaus
4 - Director of Issuer
Direct Ownership
|
Options
97 - Other
|
-3 vol |
10,309 | |
| Filed 2016-02-29 Tx date 2016-02-29 |
$NRI
Nuvo Research Inc. |
Guntermann, Henrich R.K.
4 - Director of Issuer
Direct Ownership
|
Options
97 - Other
|
-7 vol |
121,860 | |
| Filed 2016-02-29 Tx date 2016-02-29 |
$NRI
Nuvo Research Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Options
97 - Other
|
-3 vol |
10,309 | |
| Filed 2016-02-29 Tx date 2016-02-29 |
$NRI
Nuvo Research Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
97 - Other
|
+5 vol |
50,115 | |
| Filed 2016-02-29 Tx date 2016-02-29 |
$NRI
Nuvo Research Inc. |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Options
97 - Other
|
-3 vol |
10,309 | |
| Filed 2016-02-29 Tx date 2016-02-29 |
$NRI
Nuvo Research Inc. |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
97 - Other
|
+6 vol |
54,715 | |
| Filed 2016-02-29 Tx date 2016-02-29 |
$NRI
Nuvo Research Inc. |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Options
97 - Other
|
-7 vol |
182,792 | |
| Filed 2016-02-29 Tx date 2016-02-29 |
$NRI
Nuvo Research Inc. |
Lindeiner, Klaus
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
97 - Other
|
+4 vol |
48,439 | |
| Filed 2016-02-29 Tx date 2016-02-29 |
$NRI
Nuvo Research Inc. |
Lemieux, Stephen
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Options
97 - Other
|
-6 vol |
61,637 | |
| Filed 2016-01-06 Tx date 2016-01-01 |
$NRI
Nuvo Research Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
59 - Exercise for cash
|
$-426,323.88
-81,828 vol $5.21 each |
138,040 | |
| Filed 2016-01-06 Tx date 2016-01-01 |
$NRI
Nuvo Research Inc. |
Stanley, Theodore H.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
56 - Grant of rights
|
+3,810 vol |
42,334 | |
| Filed 2016-01-06 Tx date 2015-11-03 |
$NRI
Nuvo Research Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-01-06 Tx date 2016-01-04 |
$NRI
Nuvo Research Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$52,000
+10,000 vol $5.20 each |
10,000 | |
| Filed 2016-01-06 Tx date 2015-11-03 |
$NRI
Nuvo Research Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-01-06 Tx date 2016-01-01 |
$NRI
Nuvo Research Inc. |
Messier, Jacques
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
56 - Grant of rights
|
+3,810 vol |
49,763 | |
| Filed 2016-01-06 Tx date 2016-01-01 |
$NRI
Nuvo Research Inc. |
Loucaides, Katina
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
59 - Exercise for cash
|
$-208,400
-40,000 vol $5.21 each |
67,654 | |
| Filed 2016-01-06 Tx date 2016-01-01 |
$NRI
Nuvo Research Inc. |
Lindeiner, Klaus
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
56 - Grant of rights
|
+3,810 vol |
48,435 | |
| Filed 2016-01-06 Tx date 2016-01-01 |
$NRI
Nuvo Research Inc. |
Lemieux, Stephen
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
59 - Exercise for cash
|
$-240,415.45
-46,145 vol $5.21 each |
73,046 | |
| Filed 2016-01-06 Tx date 2016-01-01 |
$NRI
Nuvo Research Inc. |
Guntermann, Henrich R.K.
4 - Director of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
59 - Exercise for cash
|
$-222,748.34
-42,754 vol $5.21 each |
72,597 | |
| Filed 2016-01-06 Tx date 2016-01-01 |
$NRI
Nuvo Research Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
56 - Grant of rights
|
+3,810 vol |
50,110 | |
| Filed 2016-01-06 Tx date 2016-01-01 |
$NRI
Nuvo Research Inc. |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
56 - Grant of rights
|
+3,810 vol |
54,709 | |
| Filed 2016-01-06 Tx date 2016-01-01 |
$NRI
Nuvo Research Inc. |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
59 - Exercise for cash
|
$-426,323.88
-81,828 vol $5.21 each |
138,040 | |
| Filed 2016-01-06 Tx date 2016-01-01 |
$NRI
Nuvo Research Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
56 - Grant of rights
|
+3,810 vol |
3,810 | |
| Filed 2016-01-04 Tx date 2015-12-31 |
$NRI
Nuvo Research Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
56 - Grant of rights
|
+700 vol |
46,300 | |
| Filed 2016-01-04 Tx date 2015-12-31 |
$NRI
Nuvo Research Inc. |
Messier, Jacques
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
56 - Grant of rights
|
+1,119 vol |
45,953 | |
| Filed 2016-01-04 Tx date 2015-12-31 |
$NRI
Nuvo Research Inc. |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
56 - Grant of rights
|
+1,452 vol |
50,899 | |
| Filed 2015-12-11 Tx date 2015-12-09 |
$NRI
Nuvo Research Inc. |
Loucaides, Katina
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-5,950 vol |
0 | |
| Filed 2015-12-11 Tx date 2015-12-09 |
$NRI
Nuvo Research Inc. |
Loucaides, Katina
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$17,850
+5,950 vol $3.00 each |
8,465 | |
| Filed 2015-12-11 Tx date 2015-12-09 |
$NRI
Nuvo Research Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-10,929 vol |
0 | |
| Filed 2015-12-11 Tx date 2015-12-09 |
$NRI
Nuvo Research Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$32,787
+10,929 vol $3.00 each |
98,714 | |
| Filed 2015-12-11 Tx date 2015-12-09 |
$NRI
Nuvo Research Inc. |
Lemieux, Stephen
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-6,076 vol |
0 | |
| Filed 2015-12-11 Tx date 2015-12-09 |
$NRI
Nuvo Research Inc. |
Lemieux, Stephen
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$18,228
+6,076 vol $3.00 each |
19,652 | |
| Filed 2015-12-11 Tx date 2015-12-09 |
$NRI
Nuvo Research Inc. |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-10,929 vol |
0 | |
| Filed 2015-12-11 Tx date 2015-12-09 |
$NRI
Nuvo Research Inc. |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$32,787
+10,929 vol $3.00 each |
166,085 | |
| Filed 2015-10-01 Tx date 2015-10-01 |
$NRI
Nuvo Research Inc. |
Messier, Jacques
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
56 - Grant of rights
|
+834 vol |
44,834 | |
| Filed 2015-10-01 Tx date 2015-10-01 |
$NRI
Nuvo Research Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
56 - Grant of rights
|
+521 vol |
45,600 | |
| Filed 2015-10-01 Tx date 2015-10-01 |
$NRI
Nuvo Research Inc. |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
56 - Grant of rights
|
+1,082 vol |
49,447 | |
| Filed 2015-09-24 Tx date 2015-09-21 |
$NRI
Nuvo Research Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-399,997
-30,769 vol $13.00 each |
182,799 | |
| Filed 2015-09-24 Tx date 2015-09-21 |
$NRI
Nuvo Research Inc. |
Messier, Jacques
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-9,997
-769 vol $13.00 each |
10,312 | |
| Filed 2015-09-24 Tx date 2015-09-21 |
$NRI
Nuvo Research Inc. |
Lindeiner, Klaus
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-9,997
-769 vol $13.00 each |
10,312 | |
| Filed 2015-09-24 Tx date 2015-09-21 |
$NRI
Nuvo Research Inc. |
Guntermann, Henrich R.K.
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-399,997
-30,769 vol $13.00 each |
121,867 | |
| Filed 2015-09-24 Tx date 2015-09-21 |
$NRI
Nuvo Research Inc. |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-9,997
-769 vol $13.00 each |
10,312 | |
| Filed 2015-09-24 Tx date 2015-09-21 |
$NRI
Nuvo Research Inc. |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-399,997
-30,769 vol $13.00 each |
182,799 | |
| Filed 2015-09-24 Tx date 2015-09-21 |
$NRI
Nuvo Research Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-9,997
-769 vol $13.00 each |
10,312 | |
| Filed 2015-07-06 Tx date 2015-07-01 |
$NRI
Nuvo Research Inc. |
Stanley, Theodore H.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
56 - Grant of rights
|
+858 vol |
38,524 | |
| Filed 2015-07-06 Tx date 2015-07-01 |
$NRI
Nuvo Research Inc. |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
56 - Grant of rights
|
+1,277 vol |
48,365 | |
| Filed 2015-07-06 Tx date 2015-07-01 |
$NRI
Nuvo Research Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
56 - Grant of rights
|
+1,026 vol |
45,079 | |
| Filed 2015-07-06 Tx date 2015-07-01 |
$NRI
Nuvo Research Inc. |
Lindeiner, Klaus
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
56 - Grant of rights
|
+1,026 vol |
44,625 | |
| Filed 2015-07-06 Tx date 2015-07-01 |
$NRI
Nuvo Research Inc. |
Messier, Jacques
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
56 - Grant of rights
|
+984 vol |
44,000 | |
| Filed 2015-06-10 Tx date 2015-06-10 |
$NRI
Nuvo Research Inc. |
Loucaides, Katina
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-6,555 vol |
2,515 | |
| Filed 2015-06-10 Tx date 2015-06-10 |
$NRI
Nuvo Research Inc. |
Loucaides, Katina
8 - Deemed Insider - 6 Months before becoming Insider
Holder: RRSP (Indirect Ownership)
|
Common Shares
99 - Correction of information
|
-1 vol |
1,845 | |
| Filed 2015-06-10 Tx date 2015-06-10 |
$NRI
Nuvo Research Inc. |
Loucaides, Katina
8 - Deemed Insider - 6 Months before becoming Insider
Holder: RRSP (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+6,555 vol |
8,400 | |
| Filed 2015-06-10 Tx date 2015-06-10 |
$NRI
Nuvo Research Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Common Shares
99 - Correction of information
|
-1 vol |
87,785 |